Patent: 8,962,581
✉ Email this page to a colleague
Summary for Patent: 8,962,581
Title: | Methods and kits to identify invasive glioblastoma |
Abstract: | The invention encompasses methods and kits used in the detection of invasive glioblastoma based upon the expression of NHERF-1. The methods and kits also allow prediction of disease outcome as well as therapeutic outcome. |
Inventor(s): | Kislin; Kerri L. (Phoenix, AZ), Berens; Michael E. (Phoenix, AZ) |
Assignee: | The Translational Genomics Research Institute (Phoenix, AZ) |
Application Number: | 13/126,910 |
Patent Claims: | see list of patent claims |
Details for Patent 8,962,581
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 02/26/2004 | ⤷ Try a Trial | 2029-10-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |